A Randomized Controlled Trial of Envarsus Versus Immediate Release Tacrolimus in Kidney Transplant Recipients With Delayed Graft Function

Sandesh Parajuli,Brenda Muth,Margaret Bloom,Lucy Ptak,David Aufhauser,Carrie Thiessen,David Al-Adra,Joshua Mezrich,Nikole Neidlinger,Jon Odorico,Jacqueline Garonzik Wang,David Foley,Dixon Kaufman,Didier A. Mandelbrot

Transplantation proceedings（2023）

引用 0|浏览11

暂无评分

摘要

Envarsus patients had less fluctuation in the CNI level, requiring fewer CNI dose adjustments. However, there were no differences in the DGF recovery duration or number of dialysis treatments.

查看译文

关键词

kidney transplant recipients

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要